Format

Send to

Choose Destination
See comment in PubMed Commons below
Minerva Cardioangiol. 2012 Aug;60(4):363-73.

Gene and cell therapies for the failing heart to prevent sudden arrhythmic death.

Author information

  • 1University of Illinois at Chicago, Chicago, IL, USA.

Abstract

Current therapies for treatment and prevention of sudden cardiac death have certain limitations, and a search for new therapeutic approaches is desirable to reduce the burden of sudden arrhythmic death. Gene therapy and stem cell therapy have been investigated as new, valuable tools in treating cardiac diseases such as arrhythmias. In this review, the basics of each modality, important related experimental and clinical studies, and potential advantages and limitations of these treatments will be discussed. The future success of gene and cell therapy to become practical clinical tools greatly depends on our understanding of the mechanisms of ventricular arrhythmia and the mechanisms of action of gene and cell therapy.

PMID:
22858914
PMCID:
PMC3655203
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Minerva Medica Icon for PubMed Central
    Loading ...
    Support Center